Safer use of controlled drugs – fentanyl and buprenorphine transdermal patches

The Care Quality Commission (CQC) have received large numbers of patient safety incident reports relating to the use of fentanyl and buprenorphine patches, and oral oxycodone medicines.

Between July 2009 and July 2012 there have been 734 incidents resulting in harm from the use of fentanyl and buprenorphine patches, including eight deaths.

Between January 2010 and December 2012 there have been 801 incidents resulting in harm from the use of oxycodone, including one death.

2014 Safer Use of Controlled Drugs

appendix 1 safer controlled drugs guidance for the web fentanyl and buprenorphine transdermal patches updated

appendix 2 safer use of controlled drugs preventing harm from oral oxycodone medicines